Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Observational Study Of Reformulated BeneFIX

NCT00835068 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00835068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Observational Study Of Reformulated BeneFIX
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
October 31, 2013
Enrollment
58 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.